Liying Xing

机构：Shenyang Center for Disease Control and Prevention · ORCID：0000-0002-3301-3516

发表论文 77 篇 · 总被引 2538 次 · h-index 22

代表论文

• Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China (2021 · JAMA Network Open · 被引 214)
• Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial (2023 · The Lancet · 被引 147)
• Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials (2025 · The Lancet · 被引 42)
• Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis (2021 · Neurology · 被引 37)
• Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension (2024 · JAMA Cardiology · 被引 35)
• High Burden of Carotid Atherosclerosis in Rural Northeast China: A Population-Based Study (2021 · Frontiers in Neurology · 被引 26)